FDA DEVICE FACTS
XR-Series (XR-10, XR-20) Automated Hematology Analyzers
Sysmex America, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
XR-Series System Configurations XR-1500, XR-2000, XR-3000, and XR-9000 are integrated, modular, quantitative, multiparameter automated hematology-analyzer configurations for in vitro diagnostic screening of patient populations in clinical laboratories. Configurations contain one or more XR-10 and/or XR-20 analyzers and may include an SP-50 automated slide-preparation unit. XR-2000 contains two analyzers; XR-1500 and XR-3000 contain up to two analyzers plus an SP-50; and XR-9000 contains up to nine analyzers plus an SP-50. XR-10 and XR-20 modules classify and enumerate WBC, RBC, HGB, HCT, MCV, MCH, MCHC, PLT-I, PLT-F, NEUT percent/count, LYMPH percent/count, MONO percent/count, EO percent/count, BASO percent/count, IG percent/count, RDW-CV, RDW-SD, MPV, NRBC percent/count, RET percent/count, IPF, IPF count, IRF, and RET-He in whole blood. Body Fluid mode enumerates WBC-BF, RBC-BF, MN percent/count, PMN percent/count, and TC-BF count in cerebrospinal, peritoneal, pleural, and synovial fluids. Whole blood must be collected in K2EDTA or K3EDTA; serous and synovial fluids must use K2EDTA to prevent clotting; anticoagulants are neither required nor recommended for CSF.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。